Progression of endometrial hyperplasia to endometrial cancer · endometrial hyerplasia
It is very uncertain whether summary of findings table ‐ Metformin + megestrol changes progression of endometrial hyperplasia to endometrial cancer compared with megestrol (very low certainty).
1 finding from 1 review
Hysterectomy rate · endometrial hyerplasia
It is very uncertain whether summary of findings table ‐ Metformin + megestrol changes hysterectomy rate compared with megestrol (very low certainty).
1 finding from 1 review
Abnormal uterine bleeding ‐ not measured · endometrial hyerplasia
The review found no eligible studies for this question.
1 finding from 1 review
HRQOL ‐ not measured · endometrial hyerplasia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects during treatment · endometrial hyerplasia
1 finding from 1 review
Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium · endometrial hyerplasia
Summary of findings table ‐ Metformin + megestrol may leads to higher regression of endometrial hyperplasia (with or without atypia) to… compared with megestrol (low certainty).
1 finding from 1 review
Recurrence of endometrial hyperplasia · endometrial hyerplasia
1 finding from 1 review
Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin changes regression of endometrial hyperplasia (with or without atypia) to… compared with megestrol (very low certainty).
1 finding from 1 review
Recurrence of endometrial hyperplasia · endometrial hyperplasia
1 finding from 1 review
Progression of endometrial hyperplasia to endometrial cancer · endometrial hyperplasia
1 finding from 1 review
Hysterectomy rate · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin changes hysterectomy rate compared with megestrol (very low certainty).
1 finding from 1 review
Abnormal uterine bleeding · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin changes abnormal uterine bleeding compared with megestrol (very low certainty).
1 finding from 1 review
HRQOL ‐ not measured · endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects during treatment ‐ not reported · endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review